Amgen (AMGN) EBT (2009 - 2026)

Amgen's EBT history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• In Q1 2026, EBT rose 5.63% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $9.1 billion (up 36.65% YoY), while the FY2025 annual figure was $9.0 billion, up 94.75% from the prior year.
• EBT was $2.1 billion for Q1 2026 at Amgen, up from $1.5 billion in the prior quarter.
• In the past five years, EBT ranged from a high of $3.9 billion in Q3 2025 to a low of -$68.0 million in Q1 2024.
• Historically, EBT has averaged $1.8 billion across 5 years, with a median of $1.7 billion in 2022.
• The sharpest annual moves came in 2024 and 2025: EBT sank 101.98% in 2024, then surged 3001.47% in 2025.
• A 5-year view of EBT shows it stood at $1.7 billion in 2022, then plunged by 51.26% to $852.0 million in 2023, then slipped by 8.22% to $782.0 million in 2024, then soared by 93.61% to $1.5 billion in 2025, then soared by 37.65% to $2.1 billion in 2026.
• The last three EBT figures came in at $2.1 billion (Q1 2026), $1.5 billion (Q4 2025), and $3.9 billion (Q3 2025), per Business Quant data.